Search research articles
Contact Us
Filters
Showing results (21-30 of 138) with videos related to
Page
of 14
Sort By:
Trends in Pharmacological Sciences
|
May 21, 2026
Remibrutinib (Rhapsido) for chronic spontaneous urticaria
Erica N Lamkin, Eduardo Bravo, Justin Taylor
Blood
|
June 11, 2017
Diagnosis and classification of hematologic malignancies on the basis of genetics
Justin Taylor, Wenbin Xiao, Omar Abdel-Wahab
Translational Cancer Research
|
November 16, 2023
A big STEP (Simultaneous Tumor and Effector Profiling) forward in the battle against chimeric antigen receptor (CAR) T-cell therapy resistance
Anya K Sondhi, Carla Barrientos Risso, Justin Taylor
Genes
|
December 23, 2023
Resisting the Resistance: Navigating BTK Mutations in Chronic Lymphocytic Leukemia (CLL)
Alexandra Chirino, Skye Montoya, Anita Safronenka, et al.
Bioorganic & Medicinal Chemistry Letters
|
December 14, 2025
Therapeutic potential of STK17A targeted therapies
Hafsa Ouaakki, Eduardo Bravo, Justin Taylor, et al.
Trends in Pharmacological Sciences
|
July 18, 2024
BTK inhibitors: past, present, and future
Allison Cool, Tiffany Nong, Skye Montoya, et al.
Drugs
|
November 24, 2016
Management of Post-Liver Transplant Recurrence of Hepatitis C
Justin Taylor, Paula Cox-North, Charles S Landis
Future Science OA
|
September 3, 2025
ChatGPT's role in the rapidly evolving hematologic cancer landscape
Tiffany Nong, Sean Britton, Viralkumar Bhanderi, et al.
Obstetrics and Gynecology
|
July 23, 2009
Irinotecan use during pregnancy
Justin Taylor, Adanna Amanze, Elaine Di Federico, et al.
Trends in Immunology
|
July 19, 2022
Splicing dysregulation in human hematologic malignancies: beyond splicing mutations
Jonas De Kesel, Igor Fijalkowski, Justin Taylor, et al.
Page
of 14
Search research articles
Search
Showing results (21-30 of 138) with videos related to
Sort By:
Page
of 14
Trends in Pharmacological Sciences
|
May 21, 2026
Remibrutinib (Rhapsido) for chronic spontaneous urticaria
Erica N Lamkin, Eduardo Bravo, Justin Taylor
Blood
|
June 11, 2017
Diagnosis and classification of hematologic malignancies on the basis of genetics
Justin Taylor, Wenbin Xiao, Omar Abdel-Wahab
Translational Cancer Research
|
November 16, 2023
A big STEP (Simultaneous Tumor and Effector Profiling) forward in the battle against chimeric antigen receptor (CAR) T-cell therapy resistance
Anya K Sondhi, Carla Barrientos Risso, Justin Taylor
Genes
|
December 23, 2023
Resisting the Resistance: Navigating BTK Mutations in Chronic Lymphocytic Leukemia (CLL)
Alexandra Chirino, Skye Montoya, Anita Safronenka, et al.
Bioorganic & Medicinal Chemistry Letters
|
December 14, 2025
Therapeutic potential of STK17A targeted therapies
Hafsa Ouaakki, Eduardo Bravo, Justin Taylor, et al.
Trends in Pharmacological Sciences
|
July 18, 2024
BTK inhibitors: past, present, and future
Allison Cool, Tiffany Nong, Skye Montoya, et al.
Drugs
|
November 24, 2016
Management of Post-Liver Transplant Recurrence of Hepatitis C
Justin Taylor, Paula Cox-North, Charles S Landis
Future Science OA
|
September 3, 2025
ChatGPT's role in the rapidly evolving hematologic cancer landscape
Tiffany Nong, Sean Britton, Viralkumar Bhanderi, et al.
Obstetrics and Gynecology
|
July 23, 2009
Irinotecan use during pregnancy
Justin Taylor, Adanna Amanze, Elaine Di Federico, et al.
Trends in Immunology
|
July 19, 2022
Splicing dysregulation in human hematologic malignancies: beyond splicing mutations
Jonas De Kesel, Igor Fijalkowski, Justin Taylor, et al.
Page
of 14